Suchergebnisse - "Parfrey, Patrick S"

PubPharm (15)

1

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Sarnak, M. | Agarwal, R. | Boudville, N. | +12

2

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

enthalten in: American journal of hematology | 2022

von Koury, M. | Agarwal, R. | Chertow, G. | +16

3

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials

enthalten in: American journal of nephrology | 2022

von Agarwal, R. | Anand, S. | Eckardt, K. | +7

4

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus

enthalten in: American heart journal | 2015

von Lewis, E. | Claggett, B. | Parfrey, P. | +9

5

On peginesatide and anemia treatment in CKD

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2013

von Parfrey, P. | Warden, G. | Barrett, B.

CommentOn: N Engl J Med. 2013 Jan 24;368(4):307-19. - PMID 23343061

6

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes : an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2013

von Skali, H. | Lin, J. | Pfeffer, M. | +12

CommentIn: Am J Kidney Dis. 2013 Feb;61(2):191-3. - PMID 23318011

7

Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa : the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience

enthalten in: Circulation | 2011

von Skali, H. | Parving, H. | Parfrey, P. | +11

CommentIn: Circulation. 2011 Dec 20;124(25):2805-8. - PMID 22184042

8

Darbepoetin alfa impact on health status in diabetes patients with kidney disease : a randomized trial

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2011

von Lewis, E. | Pfeffer, M. | Feng, A. | +10

9

Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2010

von Foley, R. | Curtis, B. | Randell, E. | +1

10

Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients : a randomized trial

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2009

von Foley, R. | Curtis, B. | Parfrey, P.